HIV/AIDS and Tuberculosis
Reports from Harvard University Describe Recent Advances in HIV/AIDS and Tuberculosis
Published in Drug Week, March 23rd, 2012
2012 MAR 23 -- According to the authors of a study from Boston, Massachusetts, "In WesternEurope, NorthAmerica, andAustralia, large cohort collaborations have been able to estimate the short-term CD4 cell count-specific risk of AIDS or death in untreated human immunodeficiency virus (HIV)infected adults with high CD4 cell counts. In sub-Saharan Africa, these CD4 cell count-specific estimates are scarce."
"From 1996 through 2006, we followed up 2 research cohorts of HIV-infected adults in Cote d'Ivoire. This included follow-up off antiretroviral therapy (ART) across the entire spectrum of CD4 cell counts before the ART era, and only in patients with CD4 cell...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2012-03-23)
More Articles from Drug Week
- Pseudomonas
Yantai Institute of Coastal Zone Research Publishes Research in Pseudomonas - Glioblastomas
Yale University Reports Research in Glioblastomas - Cell Surface Receptors
Yale University Publishes Research in Cell Surface Receptors - Alcohol Oxidoreductases
Wenzhou Medical College Details Research in Alcohol Oxidoreductases - Antibiotics
Xinyang Normal University Details Research in Antibiotics - Weight Loss
Wellspring at Structure House Announces New Executive Director, Thomas Britton - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
